Citadel Advisors’s AXS Cannabis ETF THCX Stock Holding History

Citadel Advisors’s Portfolio THCX Stock Details THCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-420	Closed	-$7.09K	–	15788
2023 Q4	$7.09K	Buy	+420	New	+$6.97K	﹤0.01%	13312
2023 Q2	–	Sell	-180	Closed	-$3.87K	–	15519
2023 Q1	$3.87K	Buy	+180	New	+$4.51K	﹤0.01%	14000
2021 Q4	–	Sell	-1,420	Closed	-$182K	–	15057
2021 Q3	$182K	Sell	1,420 -770	-35%	-$113K	﹤0.01%	12117
2021 Q2	$376K	Sell	2,190 -2,330	-52%	-$408K	﹤0.01%	10724
2021 Q1	$890K	Buy	4,520 +2,130	+89%	+$417K	﹤0.01%	8398
2020 Q4	$299K	Buy	+2,390	New	+$265K	﹤0.01%	9088

Citadel Advisors's THCX Position: Q1 2024 in Review

Citadel Advisors sold out of AXS Cannabis ETF (THCX) in Q1 2024, closing a stake of 1,088 shares — an estimated $18.4K sold.

Citadel Advisors first reported a position in THCX in Q3 2019 and held it in 3 quarters. The position peaked at $243K in Q3 2019. 0 funds tracked by Wall St. Rank hold THCX as of Q1 2024.

Citadel Advisors reported no remaining AXS Cannabis ETF position as of Q1 2024 after selling out during the quarter.
Citadel Advisors sold 1,088 AXS Cannabis ETF shares in Q1 2024, an estimated $18.4K.
Citadel Advisors first reported a position in AXS Cannabis ETF in Q3 2019 and held it in 3 quarters.
Citadel Advisors's AXS Cannabis ETF position peaked at $243K in Q3 2019.
0 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.